Indian Clarity

Light. Truth. Clarity.

Loading ad...
Sports

Hawks' Porzingis sidelined 2 weeks with illness

Shams CharaniaOhm YoungmisukCloseOhm YoungmisukESPN Staff WriterOhm Youngmisuk has covered the Giants, Jets and the NFL since 2006. Prior to that, he covered the Nets, Knicks and the NBA for nearly a decade. He joined ESPNNewYork. com after working at the New York Daily News for almost 12 years and is a graduate of Michigan State University.

Hawks' Porzingis sidelined 2 weeks with illness

Credit: Go

Key Highlights

  • Follow him on »Follow on XDec 14, 2025, 04:05 PM ETEmailPrintOpen Extended ReactionsAtlanta Hawks center Kristaps Porzingis will miss the next two weeks and undergo further evaluations while dealing with a recent illness, the team announced Sunday. The Hawks said they are prioritizing the big man's health for the rest of the season.
  • The center has missed seven of his past nine games. Porzingis was diagnosed with postural orthostatic tachycardia syndrome (POTS), a disorder of the autonomic nervous system, last season when he was with the Boston Celtics.
  • Porzingis and his doctors found solutions over the summer to manage his health.
  • He entered this season saying he felt good and confident he was past what ailed him in Boston before this recent bout of illness sidelined him. Last season, Porzingis was severely slowed and was limited to averages of 7.7 points, 4.6 rebounds and 21 minutes in 11 playoff games for the Celtics. He is averaging 19.2 points, 5.6 rebounds and 1.6 blocks in 13 games this season for the Hawks.
  • Porzingis is a crucial piece to the success for the Hawks, who are hopeful of making a postseason run in the Eastern Conference. Since Nov.
Loading ad...

Sources

  1. Hawks' Porzingis sidelined 2 weeks with illness

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

Related Stories

Loading ad...